Shopping Cart 0
Cart Subtotal
USD 0

University of Arizona - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

University of Arizona (UA) is a healthcare research university that offers undergraduate and graduate degrees. The university's academic departments include cancer biology graduate interdisciplinary program, cancer biology, cellular and molecular medicine, cancer center, center for educational resources in culture, center for applied sociology, language and literacy, academic affairs, college of engineering, college of medicine, accounting, and agricultural and biosystems engineering. It also provides health services and medical center for students and employees. UA offers educational services in the areas of space sciences, optics, biosciences, arts and humanities, business, technology transfer, and others. The university includes College of Fine Arts, College of Humanities, College of Optical Sciences, College of Science and Eller College of Management is operated under the University of Arizona. UA is headquartered in Tucson, Arizona, the US.

University of Arizona-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

University of Arizona, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Arizona, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Arizona, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Arizona, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

University of Arizona, Medical Devices Deals, 2012 to YTD 2018 9

University of Arizona, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

University of Arizona, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

21st Century Oncology Enters into Research Agreement with The University of Arizona 11

PierianDx and Phoenix Children's Hospital Enter into Co-Development Agreement with University of Arizona 12

Licensing Agreements 13

Regulonix Enters into Licensing Agreement with University of Arizona 13

Reglagene Enters into Licensing Agreement with University of Arizona 14

Akhu Therapeutics Enters into Licensing Agreement with University of Arizona 15

Yumanity Therapeutics Enters into Licensing Agreement with University of Arizona 16

Teleost Enters Into Licensing Agreement with University of Arizona 17

Botanisol Enters Into Licensing Agreement with University of Arizona 18

Equity Offering 19

Synactix Pharma Spin Out from University of Arizona 19

University of Arizona-Key Competitors 20

University of Arizona-Key Employees 21

University of Arizona-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 23

Government and Public Interest 23

May 15, 2018: Enzyme's Movement May Be Key to New Cancer Drugs 23

Jan 08, 2018: USD 1.8 Million in New Funding Supports Clinical Stage Treatments 25

Nov 14, 2017: USD 8.5 million grant awarded to improve asthma care with the Navajo nation 27

Nov 14, 2017: USD 8.5M Grant Awarded to Improve Asthma Care with the Navajo Nation 28

Sep 27, 2017: Researchers Receive DOD Grant to Study Link Between Traumatic Brain Injury and Dementia 29

Jul 17, 2017: Top Cancer Research Facilities Nationwide Fueled With USD 1.2 Million In New Slate Of Grants 31

Other Significant Developments 32

Aug 03, 2018: Genome regulation of cell type cataloged in mouse at single-cell level 32

Appendix 34

Methodology 34

About GlobalData 34

Contact Us 34

Disclaimer 34


List Of Figure

List of Figures

University of Arizona, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

University of Arizona, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

University of Arizona, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

University of Arizona, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Arizona, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

University of Arizona, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Arizona, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

University of Arizona, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

University of Arizona, Pharmaceuticals & Healthcare, Key Facts 2

University of Arizona, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Arizona, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Arizona, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Arizona, Deals By Therapy Area, 2012 to YTD 2018 8

University of Arizona, Medical Devices Deals, 2012 to YTD 2018 9

University of Arizona, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

21st Century Oncology Enters into Research Agreement with The University of Arizona 11

PierianDx and Phoenix Children's Hospital Enter into Co-Development Agreement with University of Arizona 12

Regulonix Enters into Licensing Agreement with University of Arizona 13

Reglagene Enters into Licensing Agreement with University of Arizona 14

Akhu Therapeutics Enters into Licensing Agreement with University of Arizona 15

Yumanity Therapeutics Enters into Licensing Agreement with University of Arizona 16

Teleost Enters Into Licensing Agreement with University of Arizona 17

Botanisol Enters Into Licensing Agreement with University of Arizona 18

Synactix Pharma Spin Out from University of Arizona 19

University of Arizona, Key Competitors 20

University of Arizona, Key Employees 21

University of Arizona, Other Locations 22

University of Arizona, Subsidiaries 22

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

University of Arizona, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.